Biodentine
Biodentine
Biodentine
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
32<br />
6.3 - <strong>Biodentine</strong> is used as an endodontic repair<br />
material<br />
The endodontic indications of <strong>Biodentine</strong> are similar to the usual calcium silicate based<br />
materials, like the Portland cements (i.e. ProRoot ® MTA). This type of product is already<br />
well documented.<br />
Several physical, chemical and biological properties are comparable as summarised in the<br />
preclinical section. However, <strong>Biodentine</strong> has some features which are superior to MTA.<br />
• <strong>Biodentine</strong> consistency is better suited to the clinical use than MTA’s.<br />
• <strong>Biodentine</strong> presentation ensures a better handling and safety than MTA.<br />
• <strong>Biodentine</strong> does not require a two step obturation as in the case of MTA.<br />
As the setting is faster, there is a lower risk of bacterial contamination than<br />
with MTA.<br />
Adding to its ability to be used as dentine substitute, <strong>Biodentine</strong> could safely be used<br />
for each indication where dentine is damaged. Therefore, it is an advantage for the<br />
clinician and the patient (Machtou, 2009b).<br />
Moreover, a clinical trial, 09/001, aimed at assessing the tolerance and efficacy of<br />
<strong>Biodentine</strong> in 6 endodontic procedures, after 3 months and after 2 years follow-up is<br />
in progress:<br />
• Direct pulp capping following carious pulp exposure<br />
• Direct pulp capping following dental trauma/injury to healthy pulp (partial<br />
pulpotomy)<br />
• Repair of perforated root canals and/or pulp chamber floor<br />
• Retrograde endodontic surgery<br />
• Pulpotomy in primary molars<br />
• Apexification<br />
Ten patients per indication are required in this multi-centre and open-label clinical trial<br />
(Machtou, 2009a).
Change language